Sartorius (OTCMKTS:SARTF) Sees Significant Growth in Short Interest

Sartorius (OTCMKTS:SARTF) was the target of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 2,451 shares, a growth of 213.8% from the June 15th total of 781 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 189 shares, the short-interest ratio is currently 13.0 days.

Sartorius Stock Performance

Shares of Sartorius stock remained flat at $212.80 on Tuesday. The stock has a market capitalization of $7.28 billion, a price-to-earnings ratio of 98.98 and a beta of 0.98. Sartorius has a 52 week low of $181.58 and a 52 week high of $227.00. The stock has a 50-day moving average price of $211.19 and a 200 day moving average price of $220.52. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.